Phillipps Stephanie M
Known title: DirectorCIK: 0001838874
Associated companies
Transaction History
| ESAB | ▲ Buy | Option Exercise | 351 | $0 | 5/9/2025 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 618 | $0 | 5/11/2024 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 351 | $0 | 5/9/2025 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 618 | $0 | 5/11/2024 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
ESAB Schedules Q3 2026 Earnings Call Amid Mixed Stock Performance
ESAB has announced the schedule for its third-quarter 2026 earnings release and conference call. This announcement follows a period of mixed price action, with recent reports noting both sharp declines and significant gains in the stock. The company is preparing to share updated financial results as investors monitor its performance against a 52-week range of $64.83 to $137.42.
ESAB Schedules Q3 2026 Earnings Call Amid Mixed Stock Performance. ESAB has announced the schedule for its third-quarter 2026 earnings release and conference call. This announcement follows a period of mixed price action, with recent reports noting both sharp declines and significant gains in the stock. The company is preparing to share updated financial results as investors monitor its performance against a 52-week range of $64.83 to $137.42.